
University of Hyderabad incubated startup announces successful animal trials of stem cell therapy for liver failure
The Hindu
Tulsi Therapeutics achieves groundbreaking success with novel stem cell–exosome therapy for chronic liver failure at ASPIRE-BioNEST.
More Related News













